OSR Health

Q2 FY2026 EarningsQ2 FY26 results presented a significant mixed profile compared to consensus: revenue of $0.32M missed the $0.78M expectation by 59.5%, while gross margin reached 27.4% vs. the 25.0% consensus. The GAAP net loss of $1.0M was substantially narrower than the $9.28M loss expected, primarily driven by a $1.8M non-cash realized gain on financial liabilities. Diluted EPS of -$0.02 significantly beat the -$0.28 consensus, though fundamental operating losses remain persistent at $3.03M for the quarter.